ARTICLE IWarrant Agreement • December 11th, 2001 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
AMENDMENT TO THE PARTICIPATION AGREEMENT OF AUGUST 24, 1998 This Amendment to the Participation Agreement dated August 24, 1998 ("Amendment"), is entered into by and between: Ribozyme Pharmaceuticals Inc., a Delaware corporation ("Founder 1); Dr....Participation Agreement • June 16th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of January --------- 7th, 2000, among Ribozyme Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Elan International Services, Ltd., a Bermuda exempted limited -------...Securities Purchase Agreement • February 8th, 2000 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
BETWEENLicense Agreement • March 3rd, 2000 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
DEFINITIONSService Agreement • March 19th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 1.2 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. PURCHASE AGREEMENTPurchase Agreement • June 12th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
ESCROW AGREEMENTEscrow Agreement • July 1st, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 4.1 COMMON STOCK PURCHASE AGREEMENT DATED AS OF DECEMBER 29, 2000 BY AND BETWEEN RIBOZYME PHARMACEUTICALS, INC.Common Stock Purchase Agreement • January 5th, 2001 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
NEWCO REGISTRATION RIGHTS AGREEMENT -----------------------------Registration Rights Agreement • February 8th, 2000 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • November 14th, 2001 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
ARTICLE I DEFINITIONSSecurities Purchase Agreement • December 26th, 2001 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made as of --------- January 7th, 2000 by and between Ribozyme Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Elan International Services, Ltd., a Bermuda ------- exempted...Registration Rights Agreement • February 8th, 2000 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
BETWEENLicense Agreement • March 3rd, 2000 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
Ribozyme Pharmaceuticals, Inc. 3,150,000 Shares of Common Stock* (par value $.01 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • March 2nd, 2000 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 12 CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO REGULATION 240.25B-2B OF THE SECURITIES EXCHANGE ACT OF 1934. [*] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST AND IS FILED SEPARATELY...Manufacturing Agreement • March 3rd, 2000 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
SIRNA THERAPEUTICS, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 23rd, 2005 • Sirna Therapeutics Inc • Pharmaceutical preparations • New York
DEBT SECURITIES WARRANT AGREEMENT, dated as of between Sirna Therapeutics, Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “WARRANT AGENT”).
ARTICLE 1 DEFINITIONSLicense Agreement • September 18th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
EXHIBIT 10.42 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • September 18th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
andRights Agreement • December 5th, 2000 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
EXHIBIT 10.40 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. AMENDED AND RESTATED LICENSE AGREEMENT This Amended...License Agreement • May 15th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
May 29, 2001 Mr. Marvin Tancer Dear Marvin: This letter shall serve to confirm the terms of employment offered to you by Ribozyme Pharmaceuticals, Inc. (the "Company") and acknowledge your acceptance of the employment on such terms as detailed below....Employment Agreement • August 14th, 2001 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
DEFINITIONSService Agreement • June 16th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
FORM OF VOTING AGREEMENTVoting Agreement • February 14th, 2003 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
SIRNA THERAPEUTICS, INC. and [ ], AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 23rd, 2005 • Sirna Therapeutics Inc • Pharmaceutical preparations • New York
PREFERRED STOCK WARRANT AGREEMENT, dated as of between Sirna Therapeutics, Inc., a Delaware corporation (the “COMPANY”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “WARRANT AGENT”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 17th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Exhibit 10.1 RIBOZYME PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT FEBRUARY 11, 2003 TABLE OF CONTENTSCommon Stock and Warrant Purchase Agreement • February 14th, 2003 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
SECTION 1 --------- DEFINITIONSResearch Agreement • May 15th, 1998 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
Sirna Therapeutics, Inc. 9,000,000 Shares Common Stock ($0.01 par value per Share) Underwriting AgreementUnderwriting Agreement • May 24th, 2006 • Sirna Therapeutics Inc • Pharmaceutical preparations • New York
trademarks, service marks, copyrights or other proprietary information or materials of the Company or any of the Subsidiaries, and we are unaware of any facts which would form a reasonable basis for a claim of any such infringement.
FUNDING AGREEMENT FUNDING AGREEMENT made as of this 7/th/ day of January, 2000 among: (1) ELAN PHARMACEUTICAL TECHNOLOGIES, a division of ELAN CORPORATION, PLC, a public limited company incorporated under the laws of Ireland, and having its registered...Funding Agreement • February 8th, 2000 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER by and among MERCK & CO., INC., SPINNAKER ACQUISITION CORP. a wholly owned subsidiary of MERCK & CO., INC. and SIRNA THERAPEUTICS, INC. Dated as of October 30, 2006Merger Agreement • November 1st, 2006 • Sirna Therapeutics Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of October 30, 2006, by and among MERCK & CO., INC., a New Jersey corporation (“Parent”), SPINNAKER ACQUISITION CORP., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and SIRNA THERAPEUTICS, INC., a Delaware corporation (the “Company”).
Research Collaboration and License AgreementResearch Collaboration and License Agreement • May 17th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
CHINA BASIN LANDING OFFICE LEASEOffice Lease • March 31st, 2005 • Sirna Therapeutics Inc • Pharmaceutical preparations • California
This Office Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between STOCKBRIDGE/MCC-CHINA BASIN L.L.C., a Delaware limited liability company (“Landlord”), and SIRNA THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
RIBOZYME PHARMACEUTICALS, INC. 2950 Wilderness Place Boulder, Colorado 80301 USAPurchase Agreement • February 14th, 2003 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 99.4 CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO REGULATION 240.24B-2B OF THE SECURITIES EXCHANGE ACT OF 1934. [*] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST AND IS FILED...Manufacturing and Supply Agreement • June 9th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
SIRNA THERAPEUTICS, INC. Issuer andDeposit Agreement • November 23rd, 2005 • Sirna Therapeutics Inc • Pharmaceutical preparations • New York
DEPOSIT AGREEMENT, dated as of [ ] among Sirna Therapeutics, Inc., a Delaware corporation, [ ], a under the laws of the State of [ ], as Depositary, and all holders from time to time of Receipts issued hereunder.
